Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2002 1
2008 1
2012 1
2017 2
2018 3
2020 1
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lung occult large cell carcinoma"
Page 1
Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy.
Kneuertz PJ, Abdel-Rasoul M, D'Souza DM, Moffatt-Bruce SD, Merritt RE. Kneuertz PJ, et al. Clin Lung Cancer. 2023 May;24(3):e134-e140. doi: 10.1016/j.cllc.2022.12.009. Epub 2022 Dec 27. Clin Lung Cancer. 2023. PMID: 36682930 Free PMC article.

Female gender (3.1% vs. male 2.5%; P = .002) and non-squamous histology (adenocarcinoma 3.2% and large cell neuroendocrine 3.0% vs. squamous cell 1.9% tumors; P < .001) were associated with the presence of separate nodules. ...Other factors associated with

…
Female gender (3.1% vs. male 2.5%; P = .002) and non-squamous histology (adenocarcinoma 3.2% and large cell neuroendocrine 3.0 …
Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer.
Mitsui S, Tanaka Y, Jimbo N, Doi T, Tane S, Hokka D, Maniwa Y. Mitsui S, et al. Thorac Cancer. 2023 Jun;14(18):1774-1781. doi: 10.1111/1759-7714.14922. Epub 2023 May 9. Thorac Cancer. 2023. PMID: 37160414 Free PMC article.
BACKGROUND: Identifying the preoperative risk factors for lymph node upstaging could contribute to the development of individualized perioperative treatment for patients with non-small cell lung cancer (NSCLC). The current study aimed to evaluate the risk factors fo …
BACKGROUND: Identifying the preoperative risk factors for lymph node upstaging could contribute to the development of individualized periope …
Clinical Misstagings and Risk Factors of Occult Nodal Disease in Non-Small Cell Lung Cancer.
Dyas AR, King RW, Ghanim AF, Cerfolio RJ. Dyas AR, et al. Ann Thorac Surg. 2018 Nov;106(5):1492-1498. doi: 10.1016/j.athoracsur.2018.05.045. Epub 2018 Jun 15. Ann Thorac Surg. 2018. PMID: 29908981
BACKGROUND: Our objective was to compare the clinical to the pathologic stage in patients with non-small cell lung cancer (NSCLC). METHODS: A prospective database from 1 surgeon was reviewed. ...Independent predictors of occult N1 disease included high …
BACKGROUND: Our objective was to compare the clinical to the pathologic stage in patients with non-small cell lung cancer (NSC …
Molecular staging of lung and esophageal cancer.
Lau CL, Moore MB, Brooks KR, D'Amico TA, Harpole DH Jr. Lau CL, et al. Surg Clin North Am. 2002 Jun;82(3):497-523. doi: 10.1016/s0039-6109(02)00024-5. Surg Clin North Am. 2002. PMID: 12371582 Review.
Significant research to investigate the biology of NSCLC and esophageal carcinoma is ongoing, and the roles of proto-oncogenes, tumor suppressor genes, angiogenic factors, extracellular matrix proteases, and adhesion molecules are being elucidated. ...Identification of …
Significant research to investigate the biology of NSCLC and esophageal carcinoma is ongoing, and the roles of proto-oncogenes, tumor …
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Hong J, Lee J, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Sinn DH, Ahn MJ. Hong J, et al. Cancer. 2024 May 1;130(9):1693-1701. doi: 10.1002/cncr.35175. Epub 2024 Jan 2. Cancer. 2024. PMID: 38165808
BACKGROUND: The safety of immune-checkpoint inhibitors (ICIs) has not been thoroughly investigated in non-small cell lung cancer (NSCLC) patients with chronic hepatitis B (CHB) or occult hepatitis B infection (OBI). ...The secondary end points included other …
BACKGROUND: The safety of immune-checkpoint inhibitors (ICIs) has not been thoroughly investigated in non-small cell lung canc …
A Prediction Model to Optimize Invasive Mediastinal Staging Procedures for Non-small Cell Lung Cancer in Patients With a Radiologically Normal Mediastinum: The Quebec Prediction Model.
Guinde J, Bourdages-Pageau E, Collin-Castonguay MM, Laflamme L, Lévesque-Laplante A, Marcoux S, Roy P, Ugalde PA, Lacasse Y, Fortin M. Guinde J, et al. Chest. 2021 Dec;160(6):2283-2292. doi: 10.1016/j.chest.2021.05.062. Epub 2021 Jun 11. Chest. 2021. PMID: 34119514
BACKGROUND: Current guideline-recommended criteria for invasive mediastinal staging in patients with a radiologically normal mediastinum fail to identify a significant proportion of patients with occult mediastinal disease (OMD), despite it leading to a large number …
BACKGROUND: Current guideline-recommended criteria for invasive mediastinal staging in patients with a radiologically normal mediastinum fai …
Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.
Czeczok TW, Stashek KM, Maxwell JE, O'Dorisio TM, Howe JR, Hornick JL, Bellizzi AM. Czeczok TW, et al. Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):94-100. doi: 10.1097/PAI.0000000000000563. Appl Immunohistochem Mol Morphol. 2018. PMID: 29420353 Free PMC article.
Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. ...Clusterin expression was note …
Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large …
DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.
Nikolaidis G, Raji OY, Markopoulou S, Gosney JR, Bryan J, Warburton C, Walshaw M, Sheard J, Field JK, Liloglou T. Nikolaidis G, et al. Cancer Res. 2012 Nov 15;72(22):5692-701. doi: 10.1158/0008-5472.CAN-12-2309. Epub 2012 Sep 7. Cancer Res. 2012. PMID: 22962272 Free PMC article.
The exceptional high mortality of lung cancer can be instigated to a high degree by late diagnosis. ...The diagnostic efficiency of the panel did not show any biases with age, gender, smoking, and the presence of a nonlung neoplasm. However, sensitivity was predictably …
The exceptional high mortality of lung cancer can be instigated to a high degree by late diagnosis. ...The diagnostic efficiency of t …
Role of T0 status in overall survival for unresectable stage III non-small cell lung cancer: A NCDB analysis.
Komiya T, Powell E, Vu CC, Guddati AK. Komiya T, et al. Radiother Oncol. 2020 Jul;148:8-13. doi: 10.1016/j.radonc.2020.03.021. Epub 2020 Mar 26. Radiother Oncol. 2020. PMID: 32294582
OBJECTIVES: Occult primary non-small cell lung cancer (NSCLC) with mediastinal involvement is a known but rare clinical condition. ...Its prognosis and response to systemic chemotherapy have not been investigated with large scale data. MATERIALS AND ME …
OBJECTIVES: Occult primary non-small cell lung cancer (NSCLC) with mediastinal involvement is a known but rare clinical …
Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Earnest F 4th, Ryu JH, Miller GM, Luetmer PH, Forstrom LA, Burnett OL, Rowland CM, Swensen SJ, Midthun DE. Earnest F 4th, et al. Radiology. 1999 Apr;211(1):137-45. doi: 10.1148/radiology.211.1.r99ap34137. Radiology. 1999. PMID: 10189463
PURPOSE: To estimate the incidence of occult metastases to the brain and skeleton in patients suspected of having non-small cell lung cancer (NSCLC) (stage higher than T1Nomo) with surgically resectable disease, to assess the accuracy of screening magnetic re …
PURPOSE: To estimate the incidence of occult metastases to the brain and skeleton in patients suspected of having non-small cell …
15 results